Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2026-02-23 @ 1:11 AM
Study NCT ID:
NCT05868395
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2023-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma
Sponsor:
Medical University of Vienna
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-02
Start Date Type:
ACTUAL
Primary Completion Date:
2027-05-24
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-24
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-11
First Submit QC Date:
None
Study First Post Date:
2023-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-27
Last Update Post Date:
2024-05-29
Last Update Post Date Type:
ACTUAL